We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for streaming realtime charts, analysis tools, and prices.
| Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
|---|---|---|---|---|---|
| Overnet Data | LSE:OND | London | Ordinary Share | GB0031791782 | ORD 0.5P |
| Price Change | % Change | Share Price | Shares Traded | Last Trade
|
|
|---|---|---|---|---|---|
| 0.00 | 0.00% | 0.00 | - |
| Bid Price | Offer Price | High Price | Low Price | Open Price | |
|---|---|---|---|---|---|
| Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
|---|---|---|---|---|---|
| - |
| Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
|---|---|---|---|---|
| - | 0 | GBX |
Overnet Data (OND) Share Charts1 Year Overnet Data Chart |
|
1 Month Overnet Data Chart |
Intraday Overnet Data Chart |
| Date | Time | Title | Posts |
|---|---|---|---|
| 12/3/2009 | 18:20 | MARKET CAP ONLY Ј90,000 !!!! REVERSE TAKEOVER SOON? | 451 |
| 16/6/2004 | 11:48 | Overnet data stock suspension | 245 |
| 26/10/2003 | 21:06 | overnet datta - market cap Ј2m; cash 40k and falling | 5 |
| 29/8/2003 | 15:00 | Results | 132 |
| 22/8/2003 | 20:38 | OND, RTO COULD BE ON THE CARDS AT AGMS | 16 |
| Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
|---|
| Top Posts |
|---|
Posted at 12/3/2009 18:20 by kiwimonk Just dropping in to wish Good Fortune to all fellow ex-Overnetershope you are all well OND was a ride. Whats the next one? Times are mighty tough, but I there are still opportunitys down the road. KM |
Posted at 15/6/2004 14:29 by mangal Looks like most of the fickle holders have been flushed out now. The share price has risen siginificantly above the price at re-listing. |
Posted at 14/6/2004 17:37 by cat A bit of blue sky coming I think - might be worth a look in the morning:RNS Number:7486Z OverNet Data PLC 14 June 2004 Press Release OverNet Data Plc ("OverNet Data") 14 June 2004 Overnet Data Plc Announces Approval Of Acquisition And Name Change Overnet Data plc today announces the approval of the merger agreement to effect the acquisition of the entire issued share capital of FuturaGene, Inc. and change of name to FuturaGene plc ("FuturaGene" or the "Company"). The acquisition will result in the business of the Company becoming the acquisition, development and commercialisation of intellectual property licensed from a number of universities and research institutes, in the field of agricultural bio-technology. To date FuturaGene has raised over $600,000 of external capital which has allowed the Company to continue with both its research and commercial activities. Through the merger with OverNet Data approved at the EGM on 14 June 2004 the Company has raised #1.9 million (before expenses). Insinger de Beaufort, the Anglo-Dutch bank is the nominated adviser and broker to FuturaGene and carried out the successful merger and flotation on AIM. FuturaGene holds the patents for a range of gene discoveries, which confer stress tolerance in major crops. FuturaGene has obtained worldwide exclusive licences over patents on genes capable of improving crop yields under a-biotic stress, this being cold, drought and salt stress and also pathogen attack. FuturaGene's work on a saline-resistant gene is aimed at transforming salt-rich soils which account for #4bn in lost yields each year in the US. Working prototypes of the salt gene are currently undergoing evaluation in both tomato and rice plants prior to the start of field trials. This work is being conducted at Arizona University and it is planned that the gene will be licensed to a leading seed manufacturer. The implications are remarkable. A salt resistant crop, whether it be tomato, rice or wheat, could be grown in salt-rich soil or, could allow the use of low quality water for irrigation. This throws up obvious and major possibilities, such as the cultivation of crops in the Middle East, for instance, where fresh water is at such a premium. Other activities include the development of a working prototype of a drought-resistant gene and a cold-tolerant gene. Leo Knifton, Chairman commented, "The work currently being conducted seeks to enhance or reawaken genes which, because of the environments in which they have grown, have become dormant. We believe this is very important technology because currently crops in the field are only able to produce approximately 25 per cent. of their genetic potential due to their inability to respond rapidly to stresses. We contend that our work will make for a greener world - one in which plants will need fewer herbicides. This a very exciting stage in the development of FuturaGene and I look forward with great confidence to the future. It is the view of FuturaGene that these technologies are extremely important because they improve traits that have been lost in the crop species. In fact for centuries crop species have been selected to achieve higher yield and crop quality without consideration for tolerance to environmental stresses. In other words crop breeders thought there would always be fresh soil and clean water to use. Now with global climate changes and increasing pollution the situation has changed completely. Additionally most available arable land is already used for crop production and most countries are facing severe drought and salt stress. Though we are concentrating now on food crops, FuturaGene will be looking at the implications of our work on cotton, hemp and trees for instance." The Company's research partners are the Universities of Arizona, Illinois, Purdue in Indiana and California (Riverside). The approach to the commercialisation of research output is through licensing agreements with seed and agro companies. ENDS For further information please contact: Insinger de Beaufort Nandita Sahgal/Fiona Fenn Smith Tel: 020 7377 6161 This press announcement has been issued by Insinger de Beaufort on behalf of OverNet Data Plc Insinger de Beaufort is a subsidiary of Bank Insinger de Beaufort N.V. Regulated by the FSA Registered in England and Wales No. 2479169 |
Posted at 04/6/2004 07:21 by capricorn_1 Stew - I must say I find your 38p placement article quotation very intriguing. I certainly have a view on what's going on, but I've decided to keep any further calculations to myself now until after the EGM (I'll just say that the current share price must have a speculative guess between the asset value of the business and the value patented revenue future cash flows, IMO). And once OND is completed hopefully this will have provided a good test case for what to expect with VOS. |
Posted at 26/5/2004 23:17 by capricorn_1 Stew - Firstly thank-you for reviewing my points, which were mainly made to stimulate discussion. 1. You are correct the current volume of shares in circulation is 9.16M. This has now been edited. 2. You are also correct that technically this is a Placing and Acquisition...indeed it is a "float" that FuturaGene are avoiding through this RTO. 3. You state that you believe the price conditions of the placing have been fixed already. Whilst, like you, I'm sure a target placement price is set, why do they need to say a maximum of 45M shares? This implies that there is scope for movement here. 4. They state that 17.5m shares will be locked for 12months. They also say this represents 69.57% of the enlarged capital. Surely if one states a pct. like this then they are saying that they've already decided that 16M shares(17.5/0.6957 - 9.16M)will be placed onto the market on June 15th. If that's the case then what's the point of getting 45M shares authorised at the EGM? I might be wrong about this, but what if a NAV for futuragene had been set at an agreed target price, and then OND shares on the evening of the 14th June were only trading at 40p, whereas the valuation calculations had assumed 100p...wouldn't they need to issue more shares to meet that valuation? Hence the point re: "maximum". If my assumption were correct then the MMs would have an interest in stabilising the price torwards its target level, would they not...Are today's SARs not part of that process? |
Posted at 26/5/2004 20:47 by stewjames topnotch, I suspect I'm one of the "experts" you're referring to. If so, then I'd like to point out that I questioned you, not derided you.StewJames - 3 Feb'04 - 15:58 - 53 of 227 edit topnotch, I understand fully why a company would want to get an AIM listing. What I don't understand is why they would choose Overnet at 50p as the vehicle. In your own example, you would have had to relinquish equity not just to new investors in the placing but also indirectly to the existing shareholders of the company you were reversing into. In the case you cite that wouldn't have been too onerous since it would have "cost" you a few hundred grand of your company assuming terms were based on fair value at the current shareprice. In the case of any company reversing into OND, that cost would be 5M, or 10M if your quid target is to be believed. Why would you want to do that? There are other, far cheaper shells around, for example MKP trading at around net cash. Not to mention the more traditional route to obtaining a listing costs a fair bit less than a million itself. I stand by everything I said. The owners of Futuragene are surrendering a substantial portion of their company to get access to the cash. If the current valuation is at all realistic then they've been forced to accept well below that value in order to secure funding. capricorn, today's SAR shows there are 9.15M shares in issue. I don't understand where you're coming from with this: 1. The new proposed floated volume of shares will be 25.26m, hence 15m will be floated on June 15th following EGM approval (very conveniently exactly one third of the total approved share capital). Today's SAR shows there are currently 9.15M shares in issue. What's convenient about issuing exactly 1/3 of the authorised share capital? 2. OND are making an assumption of what the target share price will be on June 15th, in order to make this calculation (i.e. 17.5m / 0.6957). At current prices, the combined entity will be valued at £25m! I don't see anything in the wording of the announcement suggesting a price-dependent component. It reads as if all the conditions and prices have all been fixed. The market price makes no difference. 3. There is a provision to issue a maximum of 45m shares...this is available presumably for further share placements after the first 12months working capital runs out and/or in case the target share price upon floatation drifts lower than the current calculation. This relates to the purchase price of Futuragene. The maximum price will be 45M shares. These shares will not be used for fundraising activities (at least, not unless the conditions for their issue have passed). I'd guess there's another resolution about increasing the authorised share capital which would allow them to issue more shares for cash, although it may be high enough already that they have no need to do this. Changes in the authorised share capital don't generally mean much. Most companies have a safety net whereby they can place shares without having to consult shareholders first. Doesn't necessarily mean they will. So the next question is what is the expected float price for the shares £1, £1.5 (as someone suggested last week), 75p....who knows (besides the MMs managing them to their final destination June 15th)....but £1 so far seems to be the center of gravity for this stock. This is a placing and acquisition, not a float. The shareprice is completely irrelevant to the process. Today's RNS are interesting. Someone has taken a very large spreadbet position, presumably since the suspension was lifted. Could be a straightforward long but I'm more inclined to think it's related to the placing and acquisition somehow. Any ideas? |
Posted at 26/5/2004 09:08 by capricorn_1 Sho - I've recently bought into VOS and am hoping that they will perform a value enhancing RTO over the coming months. They are not in suspension at the moment, and with Comdirect one can buy up to 500,000 for 1.08p at present (saving of 0.17p). In fact I might buy some more myself in due course. I've now taken the trouble to read all the OND announcement. I can now see that although these are highly speculative, there is in fact some logic in holding them in the run up to the 15th June merger, especially given that most of the new shares will "locked in" for 12 months, if I've interpreted the announcement correctly.* The key for me though is the waiting time from trials of the patented technology to revenue generating activity. *edit: If there are 9.16m shares in circulation at present and we are told that the "lock-in" number of shares will be 69.57% of total new placed shares or 17.5m, then we know two important assumptions about the placement and acquisition: 1. The new proposed floated volume of shares will be 25.16m, hence 16m will be floated on June 15th following EGM approval. 2. OND are making an assumption of what the target share price will be on June 15th, in order to make this calculation (i.e. 17.5m / 0.6957). At current prices, the combined entity will be valued at £25m! 3. There is a provision to issue a maximum of 45m shares...this is available presumably for further share placements after the first 12months working capital runs out and/or in case the target share price at the time of the placement drifts lower than the current calculation. So the next question is what is the expected placement price for the shares £1, £1.5 (as someone suggested last week), 75p....who knows (besides the MMs managing them to their final destination June 15th)....but £1 so far seems to be the center of gravity for this stock. All IMO, DYOR, but interested to hear other views! |
Posted at 21/5/2004 08:24 by topnotch Just to remind you of one of the more 'informative' postings by a 'learned' traders/investors on this BBS dell314 - 12 Jan'04 - 09:33 ..... which rather suggests you lot aren't going to be getting your 50p a share that this was suspended at... AND NOW A POSTING BY TOPPY!!!!!!!! topnotch - 15 Jan'04 - 09:35 ...this would put the share price at around £1 which is what I have been lead to believe would be the true value for OND. LOLLOLLOLLOLLOLLOLLO Those who know lead - those who don't..... TopNotch |
Posted at 21/4/2004 12:45 by m1dge I am not an expert as I am about to demonstrate, but what happens to the share price will surely be dependant on the quality of the company that is reversing in to OND. In terms of any split, if the company is valued at £30M and the AIM listing is worth £3M them a 1: 10 share split is reasonable. If the market cap subsequently goes up to £100M yout total stake will go up likewise. Lets hope they have chosen a good company. For me it was money I had given up on anyway. |
Posted at 18/2/2004 17:26 by capricorn_1 Dell - I see where you are coming from, and your reasoning is valid in itself. But you know as well as I do, that speculative share investments rely strongly on a hunch for how the market is evolving and how this will directly effect one's target company. NBT's share price has been all but demolished over the past three years. The reasons are well know and not unique to NBT. But we are in 2004 in the beginnings of a new phase of growth and consolidation. I am banking on NBT gaining from this. It's announcement at the beginning of Feb suggests there is progress....but I believe there is much more which will only become clear at the time of the results. You also know as well as I do, that once we are aware of any good news, that an illiquid stock with on 16M shares in circulation, will not hang around at today's prices for long. So my philosophy with the likes of OND, NBT, NEB, VBT, DDD, and YOO (largely happened already here though), is simple: All hold great promise, the market conditions are turning their favour, and their price is still relatively low in P/E terms should they happen to continue their trend towards profitability (as I believe they all are and will) during 2004. That's a risk profile that I'm more than happy to live with and promote (you call ramp), but each should do their research and decide for themselves. Good luck with whatever you decide, but keep an eye on their progress during the next few weeks, even if you don't invest. |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
